Weiss Multi-Strategy Advisers’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,476
| Closed | -$350K | – | 795 |
|
|
2021
Q2 | $350K | Sell |
2,476
-276
| -10% | -$39K | 0.01% | 558 |
|
|
2021
Q1 | $274K | Sell |
2,752
-114
| -4% | -$11.4K | 0.01% | 578 |
|
|
2020
Q4 | $354K | Sell |
2,866
-15,134
| -84% | -$1.87M | 0.01% | 571 |
|
|
2020
Q3 | $1.75M | Buy |
18,000
+3,046
| +20% | +$297K | 0.05% | 353 |
|
|
2020
Q2 | $2.33M | Buy |
14,954
+542
| +4% | +$84.6K | 0.07% | 296 |
|
|
2020
Q1 | $2.08M | Buy |
14,412
+4,124
| +40% | +$595K | 0.08% | 240 |
|
|
2019
Q4 | $2.1M | Buy |
10,288
+7,288
| +243% | +$1.49M | 0.03% | 353 |
|
|
2019
Q3 | $241K | Buy |
+3,000
| New | +$241K | ﹤0.01% | 431 |
|